Clinical Macular Edema Following Uneventful Cataract Surgery in Eyes Without Pre-existing Fundus Diseases: Risk Factors and Treatment Prognosis

Overview

Journal BMC Ophthalmol

Publisher Biomed Central

Specialty Ophthalmology

Date 2024 Oct 1

PMID 39354377

Authors

Yingjia Lin

Biyao Xie

Shuping Ke

Weiqing Ye

Dingguo Huang

Weiqi Chen

Zijing Huang

Affiliations

Soon will be listed here.

Abstract

Background: To investigate the risk factors and prognosis of clinical pseudophakic cystoid macular edema (PCME) after uneventful phacoemulsification surgery in patients without pre-existing fundus diseases.

Methods: This was a retrospective case-control study. Medical records between August 2020 and August 2023 were reviewed for patients who had no previous fundus diseases and developed clinical PCME. A control group was randomly chosen and the risk factors for PCME was analyzed by binary logistic regression. Structure and visual prognosis of the PCME cohort were observed and compared among subgroups undergoing different treatment measures.

Results: Forty-seven eyes of 47 patients with PCME were included. The development of PCME was associated with higher systolic blood pressure (OR, 1.048; 95%CI 1.002, 1.097; P = .042), no posterior vitreous detachment (OR, 0.215; 95%CI: 0.553, 0.887; P = .032) and shorter axial lengths (OR, 0.401; 95%CI 0.161, 0.997; P = .049) compared to controls. During a mean follow-up of 8.26 months, 36 eyes (76.6%) showed visual improvement with decreased macular thickness. Different treatment modalities, including observation, topical NSAIDs, and intervention therapy, have no significant differences on the visual prognosis (P = 1.000). However, the intervention group had a shorter recovery time compared to the observation group (28.6 vs. 45.9 days, P = .037).

Conclusion: PCME remains an encountered morbidity in patients without pre-existing fundus diseases. Shorter axial lengths, absence of posterior vitreous detachment, and higher systolic blood pressure are risk factors of PCME. Active intervention failed to improve the prognosis of PCME but could shorten the recovery time.

References

GASS J, Norton E . Fluorescein studies of patients with macular edema and papilledema following cataract extraction. Trans Am Ophthalmol Soc. 1966; 64:232-49. PMC: 1310231. View

Spitzer M, Ziemssen F, Yoeruek E, Petermeier K, Aisenbrey S, Szurman P . Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg. 2008; 34(1):70-5. DOI: 10.1016/j.jcrs.2007.08.021. View

Ahmadabadi H, Mohammadi M, Beheshtnejad H, Mirshahi A . Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification. J Cataract Refract Surg. 2010; 36(6):917-22. DOI: 10.1016/j.jcrs.2009.12.030. View

Rashid S, Young L . Progression of diabetic retinopathy and maculopathy after phacoemulsification surgery. Int Ophthalmol Clin. 2010; 50(1):155-66. DOI: 10.1097/IIO.0b013e3181c555cf. View

Fernando Arevalo J, Maia M, Garcia-Amaris R, Roca J, Sanchez J, Berrocal M . Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology. 2009; 116(8):1481-7, 1487.e1. DOI: 10.1016/j.ophtha.2009.04.006. View

Jiramongkolchai K, Lalezary M, Kim S . Influence of previous vitrectomy on incidence of macular oedema after cataract surgery in diabetic eyes. Br J Ophthalmol. 2010; 95(4):524-9. DOI: 10.1136/bjo.2010.182477. View

Pendergast S, Margherio R, Williams G, Cox Jr M . Vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol. 1999; 128(3):317-23. DOI: 10.1016/s0002-9394(99)00158-0. View

Deuter C, Gelisken F, Stubiger N, Zierhut M, Doycheva D . Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases. Ocul Immunol Inflamm. 2011; 19(3):216-8. DOI: 10.3109/09273948.2011.562341. View

Framme C, Wolf S . Retinal complications after damaging the vitreolenticular barrier. Ophthalmologica. 2011; 227(1):20-33. DOI: 10.1159/000330421. View

10.

IRVINE S . A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953; 36(5):599-619. DOI: 10.1016/0002-9394(53)90302-x. View

11.

Grzybowski A, Sikorski B, Ascaso F, Huerva V . Pseudophakic cystoid macular edema: update 2016. Clin Interv Aging. 2016; 11:1221-1229. PMC: 5025006. DOI: 10.2147/CIA.S111761. View

12.

Perente I, Utine C, Ozturker C, Cakir M, Kaya V, Eren H . Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res. 2007; 32(3):241-7. DOI: 10.1080/02713680601160610. View

13.

Berisha F, Findl O, Lasta M, Kiss B, Schmetterer L . A study comparing ocular pressure pulse and ocular fundus pulse in dependence of axial eye length and ocular volume. Acta Ophthalmol. 2010; 88(7):766-72. DOI: 10.1111/j.1755-3768.2009.01577.x. View

14.

Noma H, Yasuda K, Shimura M . Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema. Int J Mol Sci. 2021; 22(7). PMC: 8036935. DOI: 10.3390/ijms22073427. View

15.

Flach A . The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1999; 96:557-634. PMC: 1298410. View

16.

Kocamis S, Boz A, Ozdemir I . Systemic immune-inflammation index could be associated with pseudophakic cystoid macular edema after an uneventful phacoemulsification surgery in patients without risk factors. BMC Ophthalmol. 2022; 22(1):378. PMC: 9494893. DOI: 10.1186/s12886-022-02606-5. View

17.

Yilmaz T, Cordero-Coma M, Gallagher M . Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review. Eye (Lond). 2011; 26(2):252-8. PMC: 3272202. DOI: 10.1038/eye.2011.296. View

18.

Belair M, Kim S, Thorne J, Dunn J, Kedhar S, Brown D . Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol. 2009; 148(1):128-35.e2. PMC: 2722753. DOI: 10.1016/j.ajo.2009.02.029. View

19.

Yonekawa Y, Kim I . Pseudophakic cystoid macular edema. Curr Opin Ophthalmol. 2011; 23(1):26-32. DOI: 10.1097/ICU.0b013e32834cd5f8. View

20.

Benitah N, Arroyo J . Pseudophakic cystoid macular edema. Int Ophthalmol Clin. 2010; 50(1):139-53. DOI: 10.1097/IIO.0b013e3181c551da. View